Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia
Christian Michel(Philipps University of Marburg), Andreas Burchert(Philipps University of Marburg), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Jennifer Kremer(Universitätsklinikum Gießen und Marburg), Sabrina Inselmann(Philipps University of Marburg), Elisabeth Mack(Universitätsklinikum Gießen und Marburg), André Marquardt(University of Würzburg), Gert Bange(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg), Andreas Neubauer(RWTH Aachen University), Clara Simon(Philipps University of Marburg), Lutz B. Jehn(Philipps University of Marburg), Kristina Sohlbach(Philipps University of Marburg), Ellen Wollmer(Philipps University of Marburg), Lea Fritz, Christopher-Nils Mais(Loewe Center for Synthetic Microbiology), Ying Wang(Aerospace Center Hospital), Sonja K. Hühn(Philipps University of Marburg)
Cited by 0
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573